If you need more lookups,
subscriptions start at $34 USD/month.
Evert-Jan Uringa Location
Arnhem, GE, NL
Evert-Jan Uringa Work
2025 -now Senior Director Business Development, Patient-derived organoid platforms @
2023 -2025 Senior Director Translational Oncology, Head of UK, Scandinavia and BeNeLux @
2022 -2023 Senior Director @
2016 -2022 Senior Scientific Business Development and Program Manager @
2010 -2015 Senior Scientist @
2006 -2010 Postdoctoral fellow @
2000 -2005 PhD student @
Evert-Jan Uringa Education
Erasmus MC Academie 2000-2005
Wageningen University & Research 1994-1999
Ichthus College (CSG Liudger, Drachten) 1988-1994
Evert-Jan Uringa Skills
Cell Biology
Molecular Biology
Genetics
Cell Culture
Western Blotting
qPCR
Biochemistry
Genomics
Molecular Cloning
Microscopy
Lifesciences
Flow Cytometry
Scientific Writing
Science
Biotechnology
Statistics
Research
PCR
Bioinformatics
DNA
Life Sciences
Cell
Fluorescence Microscopy
Stem Cells
Protein Chemistry
Transfection
Biology
Cancer Research
Molecular Genetics
Confocal Microscopy
Animal Models
Tissue Culture
Sequencing
In Vitro
Protein Expression
Immunoprecipitation
Immunofluorescence
FACS
Molecular & Cellular Biology
Cancer
Recombinant DNA
RNAi
Protein Purification
SDS-PAGE
Immunocytochemistry
DNA repair
Protein Production
Gene targeting
CRISPR
Antibodies
Sds Page
Molecular and Cellular Biology
Evert-Jan Uringa Summary
Evert-Jan Uringa, based in Arnhem, GE, NL, is currently a Senior Director Business Development, Patient-derived organoid platforms at HUB Organoids. Evert-Jan Uringa brings experience from previous roles at Champions Oncology, Inc., T-knife Therapeutics, Taconic Biosciences GmbH and ERIBA - European Research Institute for the Biology of Ageing. Evert-Jan Uringa holds a 2000 - 2005 Erasmus MC Academie. With a robust skill set that includes Cell Biology, Molecular Biology, Genetics, Cell Culture, Western Blotting and more. Evert-Jan Uringa has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Evert-Jan Uringa?
Find contact details for 700 million professionals.